The growing interest in successful weight management has led to considerable exploration into groundbreaking treatments. Lately , Retatrutide, a combined -action hormone and glucagon-like peptide-1 (GLP-1) receptor stimulator, has exhibited positive results in clinical trials, indicating potential for considerable weight reduction . Therefore, nume